Delirium Pathway - OTLPCM002-3

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

DELIRIUM CARE PATHWAY

Guidance to the detection and management of delirium in adult inpatients

1. RECOGNISE
 DELIRIUM CARE PATHWAY
History of sudden change from usual cognitive baseline (often fluctuating)
 Obtain collateral history from relative/ friend/carer/GP
 Look for: Hypoactivity, Lethargy, Reduced consciousness, Attention deficit,
Guidance to the detection
Sleep disturbance, andHyperactivity,
Hallucinations, management of delirium
slurred in adult inpatients
speech, Confusion Predisposing factors:

Age > 65 years, immobility, pain,


2. DIAGNOSE dementia, sensory impairment,
pelvic/limb/NOF #, previous
Complete 4AT (on reverse) record score and delirium diagnosis in notes episodes of delirium

 4 or above: possible delirium +/- cognitive impairment


 1-3: possible cognitive impairment
 0: delirium or severe cognitive impairment unlikely (but delirium still
possible if [4] information incomplete)

3. CONSIDER CAUSE Precipitating factors:

• Investigations: FBC, UEs, CRP, LFT, Ca, B12, Folate, TFT, Urinalysis, CXR, ECG, Infection, acute illness, surgery,
consider neuroimaging (CT/MRI), bladder scan, rule out constipation, cognitive polypharmacy, catheterisation,
impairment pain assessment scale (on intranet), medication review metabolic disorder, electrolyte
disturbance, dehydration, low
BP, hypoxia, pain, environment,
4. MANAGEMENT: START DELIRIUM CAREPLAN constipation, urine retention ,
Some medications such as
Medical Environmental steroids etc.
 Adequate lighting/use of
1. Correct and manage precipitating sensory aids (prescription
and predisposing factors glasses/hearing aids)
 Staff continuity
2. If in distress with risk to  Promotion of mobility and
self/others: senior review, encourage independence
document capacity and best  Falls prevention strategies  If no clinical
interest and consider:  Orientation aides (clock and improvement is observed
calendar) after 72 hours:
Regular short term, low dose  Promote sleep hygiene
antipsychotic (1 week or less)  Provide occupation and  Re-evaluate and
such as Haloperidol or distraction optimise management
Risperidone. Start at lowest  Oral hydration and nutrition if  Repeat 4AT
clinically appropriate dose, titrate safe to do so
cautiously according to  For further advice and
 Consider close supervision
symptoms. Contraindicated in guidance please
 Involve relatives/carers in day
Parkinson’s disease, Lewy to day management (open contact Jo Dron or Iain
body syndromes and visiting times). Offer ‘ Delirium’ Tredway on 3208
prolonged QTc. leaflet. /6845 bleep 955
In lewy body dementias and
Parkinson’s disease use Avoid: restraints; confrontation; ward
Quetiapine. moves; unnecessary interventions/ Update September 2018
3. Repeat 4AT daily until investigations; catheters; excess OTLPCM002
environmental noise
resolved
4. Repeat 4AT as often as needed

You might also like